Unrest in the ACS

Anonymous Email draws attention to controversial practices in publishing house

Written byAndrea Gawrylewski
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
An anonymous Email that was circulated on October 10 calls into question the practices of the non-profit publishing giant, the American Chemical Society (ACS), which has long been under scrutiny.The Email, signed only by "ACS insider," was sent to college librarians, ACS administrators, and a science writing listserv. It said that the ACS is growing more corporate in structure and described how it manages the 36 chemical journals under its purview. Among other criticisms, the anonymous Emailer wrote that the bonuses given to ACS executives are tied to the profits of the publishing division, and such bonuses explain why the society has had such a strong stance against open-access publishing. The anonymous author responded to requests from The Scientist for more information about his or her identity only with "I just have to remain anonymous." He or she did not provide any confirmable evidence that bonuses to executives in the society were linked to profits in the publishing division. The Email is believable, Christopher Reed, distinguished professor of chemistry at the University of California, Riverside, and outspoken critic of the ACS, told The Scientist in an Email. "Staff are intimidated about speaking out, they must do so anonymously. The profit motive has distracted ACS management from its constitutional purpose."The Email called into question the high salaries and bonuses paid to ACS CEO Madeleine Jacobs, Chemical & Engineering News editor-in-chief Rudy Baum, and president of the ACS publishing division Brian Crawford, stating that the bonuses are directly proportional to the profits of the publishing division. Crawford is also the chairman of the Association of American Publishers, who, in August, launched the controversial Partnership for Research Integrity in Science and Medicine (PRISM) coalition, an anti-open-access group.A statement sent to The Scientist from Judith Benham, chair of the ACS board of directors, said: "The anonymous author makes erroneous and misleading claims about the compensation of these employees and alleges that the compensation is somehow related to the Society's position on open access."According the tax information submitted to the IRS for fiscal year 2005, three top executives, including Bob Massie, president of Chemical Abstracts Service (CAS) -- one of ACS's most successful publications -- make more than $750,000 a year, including bonuses. Benham added that compensation for executive employees is meant to be competitive, but not higher than other publishers in the market place, and that "no ACS employee's compensation is linked to the society's positions on open access." Baum declined to say whether his bonuses were linked to publishing profits, but only that the anonymous letter had more incorrect information in it than correct information. "When anonymous material comes into the office I throw it out right away," he told The Scientist.Several former ACS employees contacted by The Scientist, who wished to remain anonymous, said that while they were employees at the ACS, it was well known that upper level managers got bonuses that were linked to publishing profits. Sylvia Ware, former director of the ACS education division, declined to comment about bonus practice at the society. As reported in Nature in January, the ACS hired a high-profile public relations firm led by Eric Dezenhall -- made famous by working with the shamed Enron chief, Jeffrey Skilling, and ExxonMobil -- to create a PR campaign against the open-access movement. In Emails leaked to The New Scientist last month, Dezenhall outlined a plan for the "coalition" -- PRISM -- to strengthen their position against open access by summoning warnings of censorship from government involvement in publishing, in addition to appealing to "elite groups of decision makers." Andrea Gawrylewski mail@the-scientist.comLinks within this article:American Chemical Society https://portal.acs.org/portal/acs/corg/memberappChristopher Reed http://chem.ucr.edu/index.html?main=faculty&facsort=profile&faculty=reedMadeleine Jacobs http://pubs.acs.org/cen/staff/biomj.htmlRudy Baum http://pubs.acs.org/cen/staff/biorb.htmlS. Ainsworth, "Brian Crawford will head ACS publications," Chemical & Engineering News? August 2, 2007 http://pubs3.acs.org/cen/news/85/i32/8532news10.htmlA. McCook, "Going anti-anti open access," The Scientist, 12 September, 2007 http://www.the-scientist.com/blog/display/53584/PRISM http://www.prismcoalition.org/J. Giles, "PR's 'pit bull' takes on open access," Nature, 445, January 25, 2007. http://www.nature.com/nature/journal/v445/n7126/full/445347a.htmlDezenhall plan http://media.newscientist.com/data/images/ns/av/sss_publishing.pdf
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella